Elisa Bandera

Employment

• Rutgers Cancer Institute of New Jersey Chief
  2018 - Present
• Rutgers, The State University of New Jersey Professor
  2015 - Present
• Rutgers, The State University of New Jersey Associate Professor of Epidemiology
  2009 - 2015
• University of Medicine and Dentistry of New Jersey Assistant Professor
  2002 - 2009
• Rutgers, The State University of New Jersey Research Scientist
  2000 - 2002

Education

• University at Buffalo - The State University of New York PhD (Epidemiology and Community Health)
  ? - 1995
• Universidad de Malaga M.D.
  ? - 1985

Projects & Funding

Projects & funding information is unavailable.

Publications (314)

• The KPROCS Study: A Real-World and Research Resource to Investigate Multilevel Determinants of Ovarian Cancer Treatment and Survival
  Cancer Epidemiology, Biomarkers & Prevention 2026 DOI: 10.1158/1055-9965.EPI-26-0765
  +Save
• Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium
  British Journal of Cancer 2026 DOI: 10.1038/s41416-026-03509-8
  +Save
• Data from Regular Physical Inactivity and Ovarian Cancer Risk in the Ovarian Cancer in Women of African Ancestry Consortium
  2026 DOI: 10.1158/1055-9965.c.8545330
  +Save
• Supplemental Table 1 from Regular Physical Inactivity and Ovarian Cancer Risk in the Ovarian Cancer in Women of African Ancestry Consortium
  2026 DOI: 10.1158/1055-9965.32730979
  +Save
• Neighborhood disorder and ovarian cancer survival in Black women
  American Journal of Epidemiology 2025 DOI: 10.1093/aje/kwaf159
  +Save
• Regular Physical Inactivity and Ovarian Cancer Risk in the Ovarian Cancer in Women of African Ancestry Consortium
  Cancer Epidemiology, Biomarkers & Prevention 2025 DOI: 10.1158/1055-9965.EPI-25-1160
  +Save
• Data from Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
  2025 DOI: 10.1158/1055-9965.c.6695948
  +Save
• Data from Neoadjuvant Chemotherapy in Ovarian Cancer: Are There Racial Disparities in Use and Survival?
  2025 DOI: 10.1158/1055-9965.c.8170213
  +Save
• Data from Race Differences in the Associations between Menstrual Cycle Characteristics and Epithelial Ovarian Cancer
  2025 DOI: 10.1158/1055-9965.c.8170022
  +Save
• Figure S1 from Associations between Etiologic or Prognostic Tumor Tissue Markers and Neighborhood Contextual Factors in Male Health Professionals Diagnosed with Prostate Cancer
  2025 DOI: 10.1158/1055-9965.30723018
  +Save